Analyst Ratings for NovoCure Ltd. (NVCR)
NVCR Rating Summary
NVCR Price Target Summary
- Highest: $42.00 (Piper Sandler)
- Lowest: $27.00 (Wedbush)
- Average: $35.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$35.50 (+127.9%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 75%
Avg. $ Target:
$35.50 (+127.9%)
* Over Last 12-Mos
Rating Score: 6.9 / 10
Percentile Rank: 75%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/2/2024 | Evercore ISI » Updated 2/27/2025 |
Vijay Kumar | Upgrade | Outperform (In Line) |
38.00 (46.00) |
20.04 (15.58) |
-22.26% | Details |
| 10/16/2024 | H.C. Wainwright » Updated 12/3/2024 |
Emily Bodnar | Upgrade | Buy (Neutral) |
38.00 (30.00) |
17.78 (15.58) |
-12.37% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
